FDA Clearance Tracker · DEN160044
Acumen Hypotension Prediction Index (HPI) Feature Software
Last checked: Nov 19, 2026Latest source record: Mar 16, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Mar 16, 2018
De Novo granted
Time to decision
536 days
Received Sep 26, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN160044
- Device name
- Acumen Hypotension Prediction Index (HPI) Feature Software
- Applicant
- Edwards Lifesciences, LLC
- Applicant location
- Irvine, CA
- Received
- Sep 26, 2016
- Decided
- Mar 16, 2018
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.2210
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN160044
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Edwards Lifesciences, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- PASCAL Precision Transcatheter Valve Repair SystemPMA supplement
P220003-S029 · Decided Oct 20, 2026 · 180 days after receipt · Panel Track
Device type: Tricuspid valve repair device, percutaneously delivered (NPS) · Cardiology
P260007 · Decided Oct 1, 2026 · 234 days after receipt
Device type: Heart-valve, polymeric (SJL) · Cardiology
K251326 · Decided Jun 11, 2026 · 408 days after receipt
Device type: Monitor, Breathing Frequency (BZQ) · Anesthesiology & Respiratory
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.